Form 4: Halliburton EVP Eric Carre Sells Shares Under 10b5-1 Trading Plan
SEC Form 4
Halliburton's EVP & Chief Financial Officer, Eric Carre, sold 14,104 shares of common stock at $26.13 per share on February 11, 2025, under a pre-arranged 10b5-1 trading plan.
Summary
- On February 11, 2025, Eric Carre, EVP & Chief Financial Officer of Halliburton, sold 14,104 shares of Halliburton common stock.
- The sale was executed at a price of $26.13 per share.
- The transaction was conducted under a Rule 10b5-1 trading plan adopted on November 12, 2024.
- Following the transaction, Carre directly owns 127,101.377 shares of Halliburton common stock.
- Carre also holds options to buy common stock at various prices and expiration dates.
Sentiment
Score: 5
Explanation: The sentiment is neutral as the transaction is a routine sale under a pre-arranged trading plan and doesn't necessarily reflect a positive or negative outlook on the company.
Industry Context
Executive stock sales are a common occurrence in publicly traded companies. They can be part of a pre-planned diversification strategy or for personal financial planning. The use of 10b5-1 trading plans allows insiders to sell shares without being accused of trading on non-public information.
Comparison to Industry Standards
- Executive compensation and stock ownership are closely monitored in the oilfield services industry.
- Companies like Schlumberger and Baker Hughes also have executives who utilize 10b5-1 plans for stock transactions.
- Comparing the holdings and trading activity of executives across these companies can provide insights into management's confidence and alignment with shareholder interests.
Stakeholder Impact
- The stock sale may have a minor impact on shareholders due to the small volume of shares sold relative to the company's total outstanding shares.
- The transaction is unlikely to significantly affect employees, customers, suppliers, or creditors.
Key Dates
| Date | Description |
|---|---|
| 12/07/2016 | Date of option grant with exercise price of $53.54, expiring 12/07/2026 |
| 12/06/2017 | Date of option grant with exercise price of $43.38, expiring 12/06/2027 |
| 12/05/2018 | Date of option grant with exercise price of $31.44, expiring 12/05/2028 |
| 11/12/2024 | Date the Reporting Person adopted the Rule 10b5-1 trading plan |
| 02/11/2025 | Date of the stock sale transaction |
| 02/12/2025 | Date of signature on the Form 4 filing |
Keywords
Halliburton, Eric Carre, Stock Sale, Form 4, 10b5-1 Trading Plan, Executive Compensation, Insider Trading
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.